Human papillomavirus 6/11 vaccine recombinant

重组（大肠杆菌）人乳头瘤病毒6/11型双价疫苗（厦门万泰沧海）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman papillomavirus 6/11 vaccine recombinant
Drug Alias NameHuman papillomavirus 6/11 vaccineHuman papillomavirus 6/11 bivalent vaccine - XiamenGecolin
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus InfectionsCondylomata Acuminata
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXiamen Innovax Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Innovax Biotech Co LtdXiamen UniversityBeijing Wantai Biological Pharmacy Enterprise Co Ltd
Inactive CompaniesN/A
Active IndicationsPapillomavirus InfectionsCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A